AIC
ABBV icon

Ambs Investment Counsel’s AbbVie ABBV Stock Holding History

Ambs Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$3.17M Sell
70,850
-20,590
-23% -$913K 1.89% 33
2013
Q2 		$3.78M Buy
+91,440
New +$4M 1.73% 31

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ambs Investment Counsel's ABBV Position: Q3 2013 in Review

Ambs Investment Counsel reduced its AbbVie (ABBV) stake by 23% in Q3 2013, selling an estimated $913K and leaving 70,850 shares worth $3.17M. The position accounts for 1.89% of the portfolio, ranked #33.

Ambs Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 2 quarters since. The position peaked at $3.78M in Q2 2013. 1,296 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

  • Ambs Investment Counsel held 70,850 shares of AbbVie worth $3.17M as of Q3 2013.
  • Ambs Investment Counsel sold 20,590 AbbVie shares in Q3 2013, an estimated $913K.
  • AbbVie made up 1.89% of Ambs Investment Counsel's portfolio in Q3 2013, its #33 holding.
  • Ambs Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 2 quarters since.
  • Ambs Investment Counsel's AbbVie position peaked at $3.78M in Q2 2013.
  • 1,296 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Ambs Investment Counsel's 13F filing for Q3 2013, filed 4 Nov 2013.